Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingObservational

The Prospective Collection, Storage and Reporting of Data on Patients

NCT ID: NCT01890486Sponsor: Wake Forest University Health SciencesLast updated: 2026-04-13

Summary

To provide the IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed.

Detailed description

To provide an IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant or cellular therapies for a disease in which a research question is not being addressed and for which peer reviewed, published data have demonstrated efficacy for this treatment approach. To provide a consent mechanism for the retrospective study of cellular products, when available, if there is a specific question to be addressed.

Outcome measures

Primary

  • Data followup

    Gather basic survival and complication data for operational and research databases for ongoing regulatory and future operational queries

    Time frame: 1 year

Eligibility criteria

Sex: AllAge: 18 Years to 120 YearsHealthy volunteers: No
Inclusion Criteria: Planned standard of care dose intensive therapy and either an allogeneic or autologous bone marrow transplant Exclusion Criteria: Participation in any other treatment research protocol

Study locations (1)

Wake Forest Baptist Health

Winston-Salem, North Carolina, 27157

Recruiting
David Hurd, MD · Contact
David Hurd, MD · Principal Investigator